Biotech group settles lengthy court battle with US rival
Manchester-based biotech company Premaitha Health has secured a legal settlement and a licence and supply partnership agreement with US-based Illumina.
This resolves their non-invasive prenatal testing (NIPT) patent infringement legal case that has been in progress for more than three years.
The litigation was over the patent of Premaitha's IONA prenatal test for Downs syndrome and other genetic disorders
The key terms of the agreements between the two companies involved Premaitha taking a licence under Illumina's patent pool... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
